News
May 1, 2024
Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain
Read more >>: Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain
April 3, 2024
Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor
Read more >>: Monteris Medical Announces Publication of Largest Cohort to Date of LITT with NeuroBlate® System for Meningioma, Most Common Primary Brain Tumor
November 8, 2023
Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients
Read more >>: Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients
April 18, 2023
Monteris Medical Announces Publication of Largest Series of NeuroBlate Laser Interstitial Thermal Therapy for Biopsy-Proven Radiation Necrosis
Read more >>: Monteris Medical Announces Publication of Largest Series of NeuroBlate Laser Interstitial Thermal Therapy for Biopsy-Proven Radiation Necrosis
October 27, 2022
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
Read more >>: Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
September 7, 2022
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
Read more >>: Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
June 1, 2022
Monteris Medical Announces Publication of Largest Cohort to Date of LITT for Treating Most Aggressive Brain Tumor
Read more >>: Monteris Medical Announces Publication of Largest Cohort to Date of LITT for Treating Most Aggressive Brain Tumor
March 16, 2022
Monteris Medical Announces Study Published on Patient Preferences for Drug-Resistant Epilepsy Treatment Options
Read more >>: Monteris Medical Announces Study Published on Patient Preferences for Drug-Resistant Epilepsy Treatment Options